Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000842023-12-000039

Options or other derivatives

  • CEO acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MELSEN GREGORY J · CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-11-30 Grant or award : show line 1 in the form Stock Option +15,000 $70.90 2019-11-29 15,000 15,000 D
Loading xslF345X03/primary_doc.xml…